Cargando…

Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk

Complement C3 binds fibrinogen and compromises fibrin clot lysis, thereby enhancing the risk of thrombosis. We investigated the role of the fibrinogen-C3 interaction as a novel therapeutic target to reduce thrombosis risk by analyzing: (i) consistency in the fibrinolytic properties of C3; (ii) bindi...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Rhodri J., Schuett, Katharina, Tiede, Christian, Jankowski, Vera, John, Vicky, Trehan, Abhi, Simmons, Katie, Ponnambalam, Sreenivasan, Storey, Robert F., Fishwick, Colin W.G., McPherson, Michael J., Tomlinson, Darren C., Ajjan, Ramzi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168514/ https://www.ncbi.nlm.nih.gov/pubmed/32354869 http://dx.doi.org/10.3324/haematol.2019.239558

Ejemplares similares

Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target
por: Alsayejh, Basmah, et al.
Publicado: (2022)

Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics
por: Pechlivani, Nikoletta, et al.
Publicado: (2021)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis
por: McPherson, Helen R, et al.
Publicado: (2021)

“Affimer” synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
por: Roper, Barnaby W.R., et al.
Publicado: (2023)

The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis
por: Smith, Gina A., et al.
Publicado: (2015)

SUN-075 Higher Fibrinogen and Clot Density in Patients with Acromegaly: The Role of Adverse Body Composition to the Increased Thrombotic Potential
por: Kyriakakis, Nikolaos, et al.
Publicado: (2019)

Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation
por: Hess, Katharina, et al.
Publicado: (2012)

Alternative reagents to antibodies in imaging applications
por: Bedford, R., et al.
Publicado: (2017)

Prolonged Inflammatory Response Post-Hypoglycemia: Mechanistic Insights Into the Relationship Between Low Glucose and Cardiovascular Risk
por: Iqbal, Ahmed, et al.
Publicado: (2022)

GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region
por: Xu, Rui-Gang, et al.
Publicado: (2021)

Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
por: Xie, Chunmei, et al.
Publicado: (2017)

VEGFR2 Trafficking, Signaling and Proteolysis is Regulated by the Ubiquitin Isopeptidase USP8
por: Smith, Gina A., et al.
Publicado: (2015)

Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function
por: Smith, Gina A., et al.
Publicado: (2017)

High fibrinogen and mixed proximal and distal thrombosis are associated with the risk of residual venous thrombosis in patients with posttraumatic deep vein thrombosis
por: Liu, Yating, et al.
Publicado: (2023)

Ultraefficient Cap-Exchange Protocol To Compact Biofunctional Quantum Dots for Sensitive Ratiometric Biosensing and Cell Imaging
por: Wang, Weili, et al.
Publicado: (2017)

Complement in Hemolysis- and Thrombosis- Related Diseases
por: Luo, Shanshan, et al.
Publicado: (2020)

Polymorphism rs2066865 in the Fibrinogen Gamma Chain (FGG) Gene Increases Plasma Fibrinogen Concentration and Is Associated with an Increased Microvascular Thrombosis Rate
por: Drizlionoka, Karina, et al.
Publicado: (2019)

D-Dimer Combined with Fibrinogen Predicts the Risk of Venous Thrombosis in Fracture Patients
por: Lin, Chaohui, et al.
Publicado: (2020)

Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders
por: Fish, Richard J., et al.
Publicado: (2021)

Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis
por: Francisco, Brenton J., et al.
Publicado: (2022)

In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis
por: Latham, Antony M., et al.
Publicado: (2014)

Complement component 5 promotes lethal thrombosis
por: Mizuno, Tomohiro, et al.
Publicado: (2017)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation
por: Bonacina, F., et al.
Publicado: (2016)

Serum Fibrinogen and Renal Dysfunction as Important Predictors of Left Atrial Thrombosis in Patients with Atrial Fibrillation
por: Golubić, Karlo, et al.
Publicado: (2023)

Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin
por: Foley, Jonathan H., et al.
Publicado: (2016)

The role of the complement system in kidney glomerular capillary thrombosis
por: Yoshida, Yoko, et al.
Publicado: (2022)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
por: Ajjan, Ramzi, et al.
Publicado: (2019)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

Complementing regeneration
por: Alawieh, Ali, et al.
Publicado: (2015)

A VE-cadherin–PAR3–α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells
por: Odell, Adam F., et al.
Publicado: (2012)

Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children
por: Huisman, Elise J., et al.
Publicado: (2021)

Epoxide based inhibitors of the hepatitis C virus non-structural 2 autoprotease
por: Shaw, Joseph, et al.
Publicado: (2015)

Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoprotease
por: Shaw, Joseph, et al.
Publicado: (2015)

Maturity onset diabetes of the young and fibrin-related thrombosis risk
por: Sagar, RC, et al.
Publicado: (2020)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_he9ealfniraap25576r66gid3e